GLASGOW, Scotland, January 30, 2013/PRNewswire –
Humanitarian project will set up infrastructure, provide expert training, validate and process samples
Life Technologies [http://www.lifetechnologies.
Life Technologies, a leader in forensic DNA technologies, will provide the infrastructure, including the expertise, training, and the forensic instruments and materials to validate the workflow and process DNA samples through its Dubai-based distributor Integrated Gulf Biosystems (IGB) [http://www.igbiosystems.com/
“It is our hope that many families will find the answers to what happened to their loved ones,” said Peter Silvester, President, Life Technologies, Europe, Middle East & Africa. “By providing the laboratory setup and forensic expertise we will help train Libyan scientists in the very latest instruments, technology and protocols to enable them in their work and help promote reconciliation in Libya.”
Life Technologies will create two separate DNA lines – one geared toward reference samples and the second focusing on processing samples from human remains. Fifty-thousand samples will be processed per year. Human remains samples will be processed using PrepFiler(R) BTA [https://products.
The laboratory will utilise the latest generation of genetic analysers and ancillary equipment and will be functionally validated under the quality assurance standards and guidelines required by the ASCLAD-LAB, SWGDAM and ISO 17025. Some training of Libyan scientists will take place in the United States under the direction and supervision of Dr. Arthur Eisenberg [https://profile.hsc.unt.edu/
“The University of North Texas Health Science Center, [http://www.hsc.unt.edu ] with its extensive experience in the identification of missing persons and human decedents, is extremely pleased to partner with Life Technologies in the training of the Libyan forensic scientists to help them complete their mission,” said Dr. Eisenberg, Director of the UNT Center for Human Identification [http://www.hsc.unt.edu/
The humanitarian project is funded in part by Repsol [http://www.repsolenergy.com/
AmpFlSTR(R) NGM SElect(TM) PCR Amplification Kit, Copan NUCLEIC-CARD(TM), MiniFiler(TM) Kit and NGM SElect(TM) Express are for forensic and paternity use only. PrepFiler(R) BTA is for research use only, not for use in diagnostic procedures.
Life Technologies Corporation [http://www.lifetechnologies.
Life Technologies’ Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies’ plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.